Dapagliflozin Propanediol Hydrate / Sitagliptin Phosphate Hydrate Tablets 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Hwa-il Pharmaceutical Co., Ltd.
MFDS item code 202200214 · Approved 2022.01.12
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is used to assist in the management of blood sugar levels in patients with type 2 diabetes who are following dietary and exercise regimens. The components sitagliptin and dapagliflozin work together to effectively help manage blood sugar. Taking this medication improves blood sugar levels to aid in the management of diabetes.
For patients taking sitagliptin 100 mg and dapagliflozin 10 mg, 1 tablet of this medicine may be taken once daily, with or without food. The tablet should be swallowed whole. No dose adjustment is necessary if the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. Do not administer this medicine if the estimated glomerular filtration rate(eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains sitagliptin and dapagliflozin as the main ingredients and is used for diabetes treatment. First, there is a risk of severe allergic reactions during the use of this medication, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you should immediately stop taking the medication and consult a doctor. Additionally, there is a risk of acute pancreatitis, which is inflammation of the pancreas, so if you experience severe abdominal pain, vomiting, or nausea, you should immediately visit a hospital. Especially, dapagliflozin included in this medication can reduce body fluid levels, leading to hypotension or kidney dysfunction, so attention should be paid if symptoms of dehydration or dizziness appear. This medication is not intended for certain patients, such as those with allergies to the main ingredients or additives, patients with type 1 diabetes, or patients undergoing dialysis. Dose adjustments are necessary for elderly patients or those with reduced kidney function, and kidney function should be regularly monitored before and during administration. Furthermore, the risk of hypoglycemia may increase when this medication is used alongside other blood sugar-lowering medications like insulin or sulfonylureas, so dosage adjustments of these medications may be necessary. During treatment, there may be a higher incidence of genital or urinary infections, so immediate treatment is required if infection symptoms occur. Women who are pregnant or breastfeeding are advised to avoid using this medication, and if pregnancy is confirmed, use should be discontinued. Finally, the safety and efficacy of this medication have not been established for children, and caution should be taken for hypoglycemic symptoms while driving or operating machinery. Regular check-ups and symptom monitoring are essential during the use of this medication, and any unusual symptoms should be discussed with a healthcare provider immediately.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius.
Bright yellow rectangular film-coated tablets
Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Hwa-il Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.